preclinical compounds

Related by string. * Preclinical : preclinical toxicology . preclinical efficacy . vivo preclinical . preclinical studies . Preclinical studies suggest . preclinical models / compounded . Compounding . Compounds . compounding . Compounded : volatile organic compounds . Volatile organic compounds . organic compounds . endocrine disrupting compounds . naturally occurring compounds * *

Related by context. All words. (Click for frequent words.) 70 HIV integrase inhibitors 70 sodium glucose transporter 69 rxRNA 68 HCV polymerase inhibitors 68 PDE4 inhibitor 67 investigational compounds 67 anticancer compounds 67 XL# XL# 67 cancer immunotherapies 67 romazarit 66 TRAIL receptor antibodies 66 ALN PCS 66 MEK inhibitor 66 antisense drugs 66 ENMD # 66 anticancer therapeutics 66 CD# CEA 65 catalytic antioxidant compounds 65 tiapamil 65 HCV nucleoside polymerase inhibitors 65 teplizumab 65 MKC# MT 64 polymerase inhibitors 64 BCR ABL inhibitors 64 MCSP respectively 64 anticoagulant reversing agent 64 MEK inhibitors 64 proteasome inhibitor 64 Nanobody 64 AKT inhibitor 64 SARMs 64 GPCR targets 64 CCR9 antagonist 64 IAP inhibitors 64 XL# XL# XL# XL# 64 orally bioavailable 64 JAK1 64 gastro intestinal inflammation 64 metaglidasen 64 orally bioavailable mimics 64 immunological diseases 64 nitric oxide donating 64 siRNA therapeutics 64 small molecule inhibitors 64 CORT # 63 therapeutic monoclonal antibodies 63 Adnectin 63 candidate CRLX# 63 isoform selective 63 ALN TTR 63 Factor VIIa 63 epothilone 63 Exelixis compounds 63 SGLT inhibitors 63 protein kinase inhibitor 63 ATL# [001] 63 selective kinase inhibitor 63 JAK inhibitor 63 novel antiviral therapeutics 63 orally administered inhibitor 63 Nanobody ® 63 Pimavanserin 63 DPX Survivac 63 multi kinase inhibitor 63 PI3K/Akt pathway inhibitor 63 Hsp# inhibitors 63 telomerase therapeutic 63 novel peptide 63 agonist compounds 63 JAK inhibitors 63 therapeutic monoclonal antibody 63 antisense inhibitors 63 vaccine GRNVAC1 63 Anticalin 63 including eniluracil ADH 63 ulimorelin 63 epothilones 63 oncolytic 63 JAK2 inhibitors 63 oral prodrug 63 histone deacetylase inhibitor 62 Nanobodies 62 RGB # 62 serine protease inhibitor CU# 62 novel antibody therapeutics 62 GVAX ® 62 highly selective adenosine 62 proprietary phage display 62 XL# anticancer compounds 62 THR beta agonist 62 Panzem R 62 alvespimycin 62 P#X# antagonist 62 Exherin 62 renin inhibitors 62 histone deacetylase HDAC 62 molecular imaging radiopharmaceuticals 62 Archexin 62 selective immunoproteasome inhibitor 62 neuropathic pain metabolic diseases 62 histone methyltransferases HMTs 62 DXL# 62 PARP inhibitors 62 oral nucleoside analogue 62 signal transduction inhibitor 62 seliciclib CYC# 62 GPR# agonist 62 antiviral compounds 62 small molecule 62 R#/MEM # 62 HCV protease inhibitors 62 monoclonal antibody therapeutics 62 adrenergic regulation 62 SAR# [002] 62 Lixivaptan 62 antiangiogenesis therapies 62 HepeX B TM 62 oncolytic virus therapies 62 nicotinic alpha 7 62 vaccines oncolytic virus 62 oncology therapeutics 62 CYT# potent vascular disrupting 62 oncolytic viruses 62 novel therapeutic antibodies 62 potently inhibit 62 highly selective endothelin 61 kinase inhibitor 61 RNA antagonists 61 myasthenia gravis Huntington 61 chemical entities NCEs 61 HQK 61 immunotherapeutic approaches 61 JAK2 inhibitor 61 humanized antibodies 61 glucokinase activators 61 preclinical 61 Aganocide ® 61 histone deacetylase HDAC inhibitor 61 proprietary LNA 61 recombinant biopharmaceutical 61 Epothilones 61 glucokinase activator 61 telomerase inhibitor drug 61 proteasome inhibitors 61 XmAb ® 61 cyclophilin inhibitors 61 Radezolid 61 HCV protease inhibitor 61 neuroprotective properties 61 HDAC inhibitors 61 otelixizumab 61 Symadex 61 NNR Therapeutics 61 anti CD3 monoclonal 61 sodium thiosulfate STS 61 PLK1 SNALP 61 investigational humanized monoclonal antibody 61 Reports Preclinical Data 61 siRNA sequences 61 humanized monoclonal antibodies 61 Mipomersen 61 IAP inhibitor 61 hematological indications 61 anticancer agents 61 delta opioid receptor 61 HCV polymerase 61 reversible inhibitor 61 Hsp# inhibition 61 candidate deforolimus 61 HepeX B 61 targeted radiotherapeutic 61 TBC# 61 recombinant polyclonal antibodies 61 selective inhibitors 61 Maxy G# 61 peptibody 61 CRTH2 61 Stapled Peptide 61 HGS ETR2 61 clinically validated targets 60 liposomal formulation 60 Serdaxin ® 60 HGS ETR1 mapatumumab 60 promising anticancer 60 HGS ETR1 60 adecatumumab MT# 60 ErbB3 HER3 60 HCD# [002] 60 RNAi therapeutic 60 neuro inflammatory 60 investigational therapies 60 Anticalins R 60 ghrelin antagonist 60 peptide therapeutics 60 M2 subunit 60 Tyrima 60 histone deacetylase 60 mda 7 60 volociximab 60 belinostat 60 Selective Electrochemical Tumor Ablation 60 CCX# 60 oral PTH 60 oral ghrelin agonist 60 Tarvacin TM 60 antibody therapeutics 60 generation proteasome inhibitor 60 Shigamabs ® 60 PNP inhibitor 60 MAXY VII 60 PI3K inhibitor 60 SIRT1 activators 60 targeting PCSK9 60 RNA therapeutics 60 thiazolides 60 Pathway Inhibitor 60 PEG SN# 60 PHX# 60 VEGF inhibitors 60 glucagon receptor 60 BHT DNA 60 Intellikine 60 OMP #M# 60 Aurora kinase 60 mertansine 60 anticancer compound 60 PRT# 60 XmAb 60 selectively modulate 60 compound INCB# 60 intranasal insulin product 60 LymphoStat B TM 60 pharmacological chaperone 60 AAG geldanamycin analog 60 AMPK activators 60 ALN HTT 60 rheumatoid arthritis thrombocytopenia 60 radezolid 60 sodium glucose cotransporter 60 lintuzumab SGN 60 Maribavir 60 Targeted Chemotherapy 60 tubulin inhibitor 60 selective androgen receptor modulator 60 IMiDs R 60 Genasense evaluating 60 HCV antiviral 60 Preclinical studies suggest 60 HGS# 60 aptamer therapeutics 60 JAK3 60 small molecule agonists 60 HDAC inhibitor 60 biodefense pathogens 60 anti CD# antibodies 60 CD# antibody [001] 60 preclinical efficacy 60 aminocandin 60 MVA BN R 60 Ostabolin C TM 60 anti secretory 60 RNAi therapeutic targeting 60 ATL# [002] 60 prolyl hydroxylase inhibitors 60 PDE# 60 kinase inhibitors 60 PSN# [002] 60 candidate XP# 60 rxRNA compounds 60 Thiarabine 60 Squalamine 60 microRNA therapeutics 60 antibody MAb 59 NovaBay Aganocide compounds 59 ASG 5ME 59 biologic therapeutics 59 immunotherapeutics 59 BRAF kinase 59 Nanobodies ® 59 humanized monoclonal antibody 59 ARIKACE ™ 59 non nucleoside HCV 59 fibrotic diseases 59 telomerase inhibitor 59 forodesine 59 Revimmune TM 59 novel immunomodulatory 59 Annamycin 59 siRNA therapeutic 59 TRV# [001] 59 Spiegelmer ® 59 novel peptides 59 renin inhibitor 59 receptor tyrosine kinase inhibitor 59 SPC# [001] 59 TLR Therapeutics 59 antisense drug 59 NU# direct 59 Dyax phage display 59 Nanobody R 59 ADCC enhanced 59 Hedgehog pathway inhibitor 59 immune stimulatory 59 selective androgen receptor modulators 59 Captisol ® 59 inflammatory autoimmune diseases 59 Cephalon Oncology 59 Talabostat 59 monoclonal antibody MAb 59 molecular chaperone regulation 59 delta isoform 59 ASONEP TM 59 antiviral therapeutics 59 DNAi 59 psoriasis rheumatoid arthritis 59 antagomirs 59 drug conjugates ADCs 59 MKC# MKC# PP 59 Curaxin CBLC# 59 tkRNAi 59 IMA# 59 novel RNAi therapeutics 59 LFRP 59 LentiVector technology 59 immune modulators 59 HSP# inhibitor 59 therapeutic antibodies 59 ISIS # 59 development peramivir neuraminidase 59 Ophthotech 59 NEUGENE R 59 AEG# 59 YONDELIS 59 Tesetaxel 59 Curaxins 59 NTDDS 59 midstage trials 59 Fleximer R 59 Insegia 59 immune modulating 59 siRNAs targeting 59 Locked Nucleic Acid 59 AtuRNAi 59 R#/MEM 59 anti amnesic 59 investigational hepatitis C 59 small molecule activators 59 OHR/AVR# 59 unpartnered 59 non nucleoside inhibitor 59 hematological tumors 59 allosteric modulator 59 ALN HPN 59 AKIP ™ 59 using ImmunoGen TAP 59 ARRY # 59 TRIOLEX HE# 59 vascular disrupting agent 59 Smac mimetics 59 delivered RNAi therapeutic 59 Cobalamin TM mediated 59 BRAF inhibitor 59 LNP formulations 59 ALN VSP 59 KinomeScan 59 Survivin antagonist 59 CDP# 59 Solazed TM 59 TLR antagonists 59 MAXY G# 59 CB2 selective 59 vosaroxin 59 novel histone deacetylase 59 IgG1 monoclonal antibody 59 polyketides 59 clinical trials Archexin ® 59 Zolinza 59 Phylomer ® 59 TKM PLK1 59 bardoxolone 59 GMX# 59 VentiRx 59 TOCOSOL Camptothecin 59 HCV protease 59 miRNA therapeutics 59 investigational pan BCR 59 beta secretase inhibitors 59 SERMs 59 A3 adenosine receptor 59 ELND-#/AZD-# 59 CEQ# 59 ionotropic glutamate receptor antagonists 59 RNAi therapeutic platform 59 Adnectins 59 novel anti infective 59 resolvins 59 reslizumab 59 therapeutic mAbs 59 Azedra 59 Fc fusion protein 59 AMPAKINE compounds 59 PI3K/mTOR 59 HuCAL antibody 59 BiTE antibody 59 FGFR 59 Canvaxin TM 59 HepDirect 59 midstage studies 59 molecular imaging radiopharmaceutical 59 GRN# 58 IMiDs ® 58 INS# [001] 58 Delafloxacin 58 Phase IIb clinical trials 58 HIV integrase inhibitor 58 favorable pharmacokinetic profile 58 Isis antisense 58 next generation URAT1 58 proprietary BiTE ® 58 small molecule glucokinase 58 dAbs 58 small molecule defensin 58 unique PER.C6 58 ATG Fresenius S 58 immunotherapeutic 58 hematological cancers 58 small molecule inhibitor 58 Dapagliflozin 58 anti infective compounds 58 compound COTI 58 docetaxel Taxotere R 58 commercialize becocalcidiol patented 58 ZFP Therapeutics 58 ArQule Kinase Inhibitor Platform 58 kidney urologic 58 PROfusion 58 subsidiaries visit http:/www.apricusbio.com 58 investigational monoclonal antibody 58 carcinoid syndrome diabetes 58 anionic backbone 58 Hsp# Inhibitor 58 developing TB4 58 leading oral taxane 58 humanized antibody 58 5 HT6 58 orphan GPCRs 58 apricitabine ATC 58 Sym# 58 angiogenesis inhibitor 58 NNRs 58 lomitapide 58 2 methoxyestradiol 58 Phase 2a clinical trials 58 Aganocide 58 Nektar pulmonary 58 Tumour Vascular Disrupting Agent 58 Rigel R# 58 SuperAntibody 58 IMC #B 58 mGluR2 NAM 58 Surfaxin LS 58 topical anti infective 58 staphylococcal vaccine 58 Chimigen TM 58 myelofibrosis polycythemia vera 58 Aegera 58 GKAs 58 oral picoplatin 58 cMET 58 OvaRex ® MAb 58 polysaccharide polymer 58 vivo validation 58 regorafenib 58 AN# novel 58 atacicept 58 elotuzumab 58 muscarinic receptor agonist 58 IMiDs 58 oxidative stress inducer 58 adenosine A2A 58 TKB# 58 rxRNA ™ compounds 58 sapacitabine CYC# 58 Zoraxel TM 58 Alfacell proprietary ribonuclease 58 ZFP Therapeutic 58 AGS PSCA 58 class mGluR5 inhibitor 58 Listeria vaccine 58 tranilast 58 Daclizumab 58 Posiphen 58 MEK inhibitor RDEA# 58 NEUGENE 58 mGluR4 58 Cetrorelix 58 Receptors GPCRs 58 CYC# 58 ZK EPO 58 Aurora kinase inhibitors 58 Fleximer 58 Exherin TM 58 commercializes therapeutics 58 Delta opioid receptor 58 ASONEP 58 talactoferrin 58 targeting CD# 58 platforms GVAX 58 Pancreate 58 Kosan dependence 58 Curaxin 58 Guanilib 58 drug pipeline TAFA# 58 Hedgehog pathway 58 Provectus Pharmaceuticals specializes 58 selective inhibitor 58 JAK#/JAK# 58 XmAb# 58 Anticalins 58 Tarmogen 58 cilengitide 58 cancer therapeutics 58 Ampakine compounds 58 Virulizin 58 Perifosine 58 bafetinib 58 immunotherapeutic agent 58 GAP #B# 58 Vaccinex 58 small molecule tyrosine 58 DGAT1 inhibitors 58 Personalized Immunotherapy 58 highly selective inhibitor 58 clinical trials SGN 58 Tranzyme 58 human monoclonal antibody 58 Ceflatonin R 58 TELINTRA 58 phosphatidylserine PS targeting 58 Initiates Phase II 58 OGeS 58 tezampanel 58 fusion inhibitor 58 oral proteasome inhibitor 58 cathepsin K inhibitor 58 immunotherapeutic vaccine 58 hypoxia activated prodrug 58 JAK2 kinase 58 Taligen 58 entinostat 58 BENLYSTA ® 58 Endotis 58 proprietary PEGylation 58 multitargeted 58 Evoltra ® 58 Neo Kidney Augment ™ 58 generation URAT1 inhibitor 58 Epothilone D 58 MOR# 58 mimetic compounds 58 YONDELIS R 58 Phase 2b clinical trials 58 LymphoStat B belimumab 57 intranasal formulation 57 generation antisense 57 MT#/MEDI-# 57 VitiGam 57 #ME# 57 nucleoside analogs 57 Vegenics 57 PDGF receptor 57 RenaZorb 57 huN# DM1 57 recombinant subunit vaccine 57 Prodarsan R 57 siRNA compounds 57 SLx 57 tremelimumab 57 HuLuc# 57 synthetic retinoid 57 Presents Preclinical 57 OncoVex 57 RNAi therapeutic targeting PCSK9 57 Angiocept 57 Synavive 57 selective kinase inhibitors 57 lysosomal storage disorders 57 novel VDA molecule 57 Hybridon 57 neuronal nicotinic receptors NNRs 57 ALS #-# 57 GPR# agonists 57 GLPG# 57 TLR9 agonists 57 3 kinase PI3K 57 immunomodulating 57 ocular formulation 57 PEGylated interferon 57 R roscovitine 57 TLR8 57 activate SIRT1 57 sirtuin modulators 57 drugs apaziquone 57 KSP inhibitor 57 ADP receptor antagonist 57 OMP #R# 57 PDE# inhibitors 57 Neo Kidney Augment 57 Quinamed R 57 Adenosine Therapeutics 57 sulfonylhydrazine class 57 Presents Preclinical Data 57 fatty acid amide hydrolase 57 telomerase activators 57 therapeutic antibody 57 Intarcia 57 oxazolidinone 57 Wnt signaling pathway 57 AVP #D# 57 skeletal sarcomere activators 57 molecular biomarkers 57 Janus Kinase 57 lipopeptide 57 targeted anticancer biopharmaceuticals 57 Nasdaq MITI biopharmaceutical 57 TKM ApoB 57 ART# 57 nucleoside tide 57 enhance ApoA 57 Bicifadine 57 Debio 57 HuCAL antibodies 57 agonistic human 57 VaxImmune 57 immune modulator 57 ErbB3 57 HDL Mimetic Peptide 57 mRNA antagonists 57 HDAC Inhibitor 57 Elagolix 57 infectious diseases autoimmune diseases 57 Anaphore 57 FOLOTYN ® 57 gamma secretase inhibitor 57 OvaRex R 57 enzastaurin 57 Zalypsis 57 vascular disrupting agents 57 Lupuzor 57 drug conjugates 57 therapeutic peptide 57 nebulized budesonide 57 chemically modified siRNA 57 Prodarsan ® 57 anti fibrotic 57 PORxin TM 57 LY# [003] 57 Onco TCS 57 somatostatin analogue 57 dermatology therapies 57 Vilazodone 57 cholesteryl ester transfer 57 Gleevec imatinib mesylate 57 pharmacological chaperones 57 CTAP# Capsules 57 SCIB1 57 XmAb ™ 57 Celator 57 maturation inhibitor 57 TRIOLEX ™ 57 danoprevir 57 oral immunomodulatory 57 RELOVAIR ™ 57 Cintredekin Besudotox 57 rNAPc2 57 Allovectin 7 R 57 phage display technology 57 Albugon 57 developing Zerenex TM 57 encapsulates siRNAs 57 prodrugs 57 Tarvacin Anti Cancer 57 VEGFR2 inhibitor 57 G Protein Coupled 57 biased ligand 57 dasatinib Sprycel 57 Aurora kinases 57 brain penetrant 57 RAF kinase 57 acetonide FA 57 oral JAK1 57 preclinical studies 57 delay bone metastases 57 synthetic cannabinoid compounds 57 TÎ ² 4 57 cyclophilin inhibitor 57 Hsp# inhibitor 57 selective angiogenic kinase inhibitor 57 HuMax TAC 57 predictive biomarkers 57 CB2 receptor selective 57 PhaseBio 57 Carfilzomib 57 ddRNAi 57 REMOXY ® 57 histone deacetylase HDAC inhibitors 57 OncoVEX GM CSF 57 daclizumab 57 secretory phospholipase A2 sPLA2 57 rheumatoid arthritis psoriasis Crohn 57 DOS# 57 tafamidis 57 Bendavia 57 ruxolitinib 57 Sapacitabine 57 polymer conjugate technology 57 neuro inflammatory disorders 57 small molecule thrombopoietin 57 GeneICE 57 Omacetaxine 57 perifosine novel potentially 57 inhibitor PPI 57 candidates Azedra TM 57 EP #R 57 Protein Kinase C 57 Aganocide R 57 developing ACAPODENE 57 TLR9 agonist 57 MorphoSys proprietary 57 carbohydrate polymers 57 prostone 57 Syncria 57 selective modulator 57 OXi# 57 Survivin 57 OncoVEX 57 Ostarine ™ 57 hemorrhagic fever viruses 57 selective orally bioavailable 57 Inc CRIS 57 reversible inhibitors 57 IL# PE 57 Potelligent Technology 57 midstage clinical trials 57 antisense inhibitor 57 HCV RNA polymerase 57 RenaZorb TM 57 OncoMed 57 Nektar proprietary 57 include VALSTAR TM 57 therapeutics 57 potent inhibitors 57 InterfeRx TM 57 Davanat 57 Onconase 57 polymerase inhibitor 57 Homspera TM 57 sirtuin therapeutics 57 product platforms GVAX 57 Smac mimetic 57 FoldRx 57 Hsp# chaperone system 57 AvalonRx 57 Myocet 57 urocortin 2 57 Deforolimus 57 FLT3 57 Gleevec resistant 57 Zemiva TM 57 systemic RNAi therapeutic 57 delipidation 57 Inc. NASDAQ TRGT 57 virus HCV protease inhibitor 57 vinca alkaloid 57 Initiates Clinical 57 NS5b 57 ABL inhibitor 57 insulin sensitizer 57 XL# XL# XL# 57 small molecule modulators 57 oral NKTR 57 adrenal steroid hormones 57 Protectans 57 serious systemic Staphylococcal 57 ImmunoGen TAP technology 57 faropenem 57 URG# 57 Novosom 57 ovarian cancer chronic hepatitis 57 selectively inhibit 57 Galenea 57 Pharmos pipeline 57 Hedgehog signaling pathway 57 imatinib Gleevec ® 57 JVRS 57 radiation sensitizer 57 NS5A 57 SPP# [002] 57 systemic RNA interference 57 RNA antagonist 57 drug ISA# 57 diagnostic biomarker 57 Pentad TM 57 Aurexis 57 Xcytrin R 57 REGN# 56 engineered proteases 56 cutaneous T 56 LHRH antagonists 56 4SC AG ISIN DE# 56 mGluR4 PAM 56 non alcoholic steatohepatitis 56 Anticalin R 56 Announces Poster Presentations 56 outlicensing 56 MKC# 56 Tß4 56 hematological malignancies 56 Olaparib 56 Oracea TM 56 interferon lambda 56 monoclonal antibodies 56 delafloxacin 56 Cylene 56 PLX# 56 protein tyrosine phosphatase 1B 56 NYSE Amex NBY clinical 56 Viamet 56 PER.C6 r 56 human antibody therapeutics 56 TRACON Pharmaceuticals 56 OXIGON TM 56 ospemifene 56 systemic RNAi 56 EHT AGN 56 Ception Therapeutics 56 TREANDA 56 derivatives Radilex TM 56 deforolimus 56 microtubule inhibitor 56 purinergic receptors P#X# 56 PCK# 56 delta gamma agonist 56 commercialize Aganocides 56 MGCD# [001] 56 cyclin dependent kinases 56 Nasdaq IMGN biotechnology 56 TG# [003] 56 HSP# inhibitors 56 molecular therapeutics immunotherapies 56 eniluracil 56 XP# XP# 56 pharmacological chaperone compounds 56 sodium Injection 56 biotherapeutic drugs 56 Adnexus Therapeutics 56 receptor modulators 56 nucleoside analog 56 peptidic compound 56 HIV maturation inhibition 56 Tasimelteon 56 AP# [003] 56 compound PMX # 56 protein tyrosine phosphatases 56 Symphogen 56 DepoVax ™ 56 ApoB SNALP 56 Factor Receptor 56 #beta HSD1 56 antibody fragment therapeutics 56 prophylactic vaccines 56 IMiD 56 include PLX IBD 56 prophylactic vaccine 56 pan HDAC inhibitor 56 Diamyd ® 56 cosmetic cosmeceutical products 56 nucleoside analogues 56 treat refractory angina 56 Neurimmune 56 nucleotide analog 56 Interferon alpha 56 receptor inhibiting monoclonal 56 Aurora kinase inhibitor 56 Seliciclib 56 aldehyde dehydrogenase ALDH2 deficiency 56 targeted radiotherapeutics 56 Nasdaq RXII 56 PRTX 56 RAS MAPK pathway 56 preclinically 56 Janus kinase 56 ONCONASE R 56 dacetuzumab 56 Aflibercept 56 TRIOLEX HE# APOPTONE HE# 56 motesanib 56 mitogen activated ERK kinase 56 SinuNase ™ 56 HCV NS5B polymerase 56 Alocrest 56 IMC A# 56 Neugene 56 novel DACH platinum 56 NXL# 56 Bezielle 56 Vidofludimus 56 inhibit viral replication 56 tezampanel NGX# 56 HepDirect R 56 candidate ATHX 56 PentaStaph 56 huC# DM4 56 nab docetaxel 56 CINOD 56 Pradefovir 56 InterfeRx 56 mGluR5 negative 56 CBLC# 56 GSK3B 56 tubulin inhibitors 56 MAbs 56 mAbs 56 tests miRview TM 56 Virium 56 POSIDUR TM ELADUR TM 56 PDE7 56 diabetes irritable bowel 56 epigenetic biomarkers 56 NF kB Decoy 56 Onalta ™ 56 KL4 surfactant 56 romidepsin novel 56 Golimumab 56 Pervasis 56 EndoTAG 56 midstage clinical 56 theranostic 56 kinase inhibition 56 gefitinib Iressa 56 humanized monoclonal 56 cannabinor 56 clinical trials dacetuzumab SGN 56 MDRNA proprietary 56 peptidomimetic 56 CRLX# 56 TACI Ig 56 lumiliximab 56 Triolex 56 Unit Dose Budesonide 56 molecular imaging pharmaceuticals 56 LAS# [002] 56 Plicera 56 antisense 56 Onalta 56 leukotriene pathway 56 Shigamabs R 56 infectious diseases autoimmune 56 Inc MEDX 56 SAR# [004] 56 squalamine 56 Combivir Kivexa 56 drug GAP #B# 56 Homspera ® 56 human IgG1 monoclonal 56 Miraxion Amarin lead 56 recombinant antibodies 56 RECOTHROM R 56 prokinetic agent 56 Nicotine Conjugate Vaccine 56 ESBA# 56 MTP inhibitor 56 lead molecular radiotherapeutic 56 apply Enhanze technology 56 HyperAcute 56 MSCRAMM R 56 2 inhibitor CYT# 56 trastuzumab DM1 T DM1 56 cognitive impairment associated 56 VEGF receptors 56 product platforms AZX# 56 5 HT2A inverse 56 Azedra TM 56 Panzem R NCD 56 Azedra ™ 56 POTELLIGENT ® 56 Sphingomab TM 56 Beta catenin 56 CB1 antagonists 56 Aerosurf 56 solanezumab 56 HCV nucleotide polymerase inhibitor 56 oral Hsp# inhibitor 56 Antisense 56 QuatRx 56 JAK3 inhibitor 56 androgen receptor antagonist 56 oral Factor Xa 56 PEGylated

Back to home page